IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms
Open Access
- 18 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Advanced Research
- Vol. 54, 195-210
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- CIHR ICR
This publication has 72 references indexed in Scilit:
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- IQGAP2, A candidate tumour suppressor of prostate tumorigenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascadeNature Cell Biology, 2008
- IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowthJournal of Cell Science, 2007
- Priming of Centromere for CENP-A Recruitment by Human hMis18α, hMis18β, and M18BP1Developmental Cell, 2007
- Essential Mitotic Functions of DNA Topoisomerase IIα Are Not Adopted by Topoisomerase IIβ in Human H69 CellsJournal of Biological Chemistry, 1998